Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver Injury

NCT06547229 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT06547229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06547229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver Injury
Lead sponsor
Beijing Friendship Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
July 15, 2024
Completion date
June 30, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent drug-induced liver injury